XML 65 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Segment, Geographic, and Concentration Risk Information (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Summary of Revenue by Segments

Segment information is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Total revenue:

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

26,866

 

 

$

38,851

 

 

$

20,562

 

Global Supply Chain Platform

 

 

28,471

 

 

 

20,491

 

 

 

33,970

 

Commercial Platform

 

 

66,991

 

 

 

89,572

 

 

 

50,427

 

Total revenue for reportable segments

 

 

122,328

 

 

 

148,914

 

 

 

104,959

 

Intersegment revenue

 

 

(2,147

)

 

 

(4,523

)

 

 

(3,730

)

Total consolidated revenue

 

$

120,181

 

 

$

144,391

 

 

$

101,229

 

Summary of Revenue by Product Group

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Total revenue by product group:

 

 

 

 

 

 

 

 

 

Commercial product sales

 

$

86,766

 

 

$

101,590

 

 

$

67,411

 

License fees

 

 

26,832

 

 

 

38,827

 

 

 

20,100

 

API sales

 

 

3,986

 

 

 

3,599

 

 

 

12,733

 

Contract manufacturing revenue

 

 

1,512

 

 

 

85

 

 

 

391

 

Medical device sales

 

 

 

 

 

 

 

 

 

Other revenue

 

 

1,085

 

 

 

290

 

 

 

594

 

Total consolidated revenue

 

$

120,181

 

 

$

144,391

 

 

$

101,229

 

Summary of Segment Information

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net loss attributable to Athenex, Inc.:

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

(118,089

)

 

$

(89,189

)

 

$

(100,919

)

Global Supply Chain Platform

 

 

(38,566

)

 

 

(15,404

)

 

 

(8,086

)

Commercial Platform

 

 

(35,382

)

 

 

(37,590

)

 

 

(14,255

)

Segment total

 

 

(192,037

)

 

 

(142,183

)

 

 

(123,260

)

Discontinued operations

 

 

(7,731

)

 

 

(3,996

)

 

 

(489

)

Total consolidated net loss attributable to Athenex, Inc.

 

$

(199,768

)

 

$

(146,179

)

 

$

(123,749

)

Summary of Depreciation, Amortization and Assets by Segment

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Total depreciation and amortization

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

879

 

 

$

776

 

 

$

762

 

Global Supply Chain Platform

 

 

1,982

 

 

 

2,017

 

 

 

1,479

 

Commercial Platform

 

 

1,821

 

 

 

1,668

 

 

 

1,566

 

Segment total

 

 

4,682

 

 

 

4,461

 

 

 

3,807

 

Discontinued operations

 

 

321

 

 

 

31

 

 

 

10

 

Total depreciation and amortization

 

$

5,003

 

 

$

4,492

 

 

$

3,817

 

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Total assets:

 

 

 

 

 

 

Oncology Innovation Platform

 

$

131,432

 

 

$

234,153

 

Global Supply Chain Platform

 

 

54,775

 

 

 

83,732

 

Commercial Platform

 

 

53,113

 

 

 

51,089

 

Segment total

 

 

239,320

 

 

 

368,974

 

Discontinued operations

 

 

28,128

 

 

 

15,355

 

Total assets

 

$

267,448

 

 

$

384,329

 

 

Summary of Revenue by Geographical Segment

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Total revenue

 

 

 

 

 

 

 

 

 

United States

 

$

114,457

 

 

$

82,362

 

 

$

67,794

 

China

 

 

2,666

 

 

 

39,796

 

 

 

2,105

 

South Korea

 

 

1,112

 

 

 

2,354

 

 

 

513

 

India

 

 

906

 

 

 

 

 

 

3,066

 

Austria

 

 

115

 

 

 

226

 

 

 

4,422

 

Spain

 

 

47

 

 

 

 

 

 

20,000

 

United Kingdom

 

 

 

 

 

19,289

 

 

 

1,023

 

Other foreign countries

 

 

878

 

 

 

364

 

 

 

2,306

 

Total consolidated revenue

 

$

120,181

 

 

$

144,391

 

 

$

101,229

 

Summary of Property and Equipment by Geographical Segment

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Total property and equipment, net:

 

 

 

 

 

 

United States

 

$

4,196

 

 

$

4,933

 

China

 

 

23,782

 

 

 

18,877

 

Total property and equipment, net

 

$

27,978

 

 

$

23,810

 

Summary of Customer Revenue and Accounts Receivable Concentration

Customer revenue and accounts receivable concentration amounted to the following for the identified periods:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Percentage of total revenue by customer:

 

 

 

 

 

 

 

 

 

Customer A

 

 

23

%

 

 

 

 

 

20

%

Customer B

 

 

17

%

 

 

10

%

 

 

14

%

Customer C

 

 

16

%

 

 

14

%

 

 

15

%

Customer D

 

 

16

%

 

 

14

%

 

 

16

%

Customer E

 

 

 

 

 

26

%

 

 

0

%

Customer F

 

 

 

 

 

13

%

 

 

0

%

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Percentage of total accounts receivable by customer:

 

 

 

 

 

 

Customer A

 

 

35

%

 

 

24

%

Customer B

 

 

29

%

 

 

33

%

Customer C

 

 

15

%

 

 

16

%